Inc. ("Shrink") (OTCBB: INKN), an innovative nanotechnology company that
develops products, licenses its patent-pending technologies and acquires related
assets in three core vertical markets: (i) medical diagnostics and sensors,
(ii) biotechnology research and development tools and (iii) solar energy production,
today announced that it plans to present at the Rodman and Renshaw Annual Global
Investment Conference in New York on Friday, September 11, 2009 at 11:40 a.m.
ET. The presentation will be held at the New York Palace Hotel in the Hubbard
Salon (5th floor).
Presenting at the conference will be Dr. Michelle Khine, scientific founder,
and Dr. Heiner Dreismann, director and expert in biotech and healthcare industries.
Dr. Khine was recently named by MIT Technology Review as one of the top 35 global
innovators under the age of 35. She is a veteran entrepreneur, with a successful
venture-capitalist (Series B) backed company, in addition to being a widely
published researcher, with multiple patents grants and honors. Currently, she
is Assistant Professor of Bioengineering at University of California in Irvine.
Dr. Dreismann has more than 24 years experience in the biotech and healthcare
industries and served as the President and CEO of Roche Molecular Systems, Inc.,
leading a staff of more than 1,600 and growing the RMS molecular IVD business
from $640M to $1.2B in annual sales.
Shrink is a FIGA™ business - bringing together leaders from the worlds
of finance, industry, government and academia. This presentation is an example
of Shrink bringing together industry leaders and academia in one setting.
Attendees will be given an overview of the Company's operations and strategic
priorities, and review opportunities for its innovative technologies and intellectual
property within the medical diagnostics and biotechnology sectors. Specific
products that will be discussed include:
- StemDisc™ - embryoid body (EB) development platform for stem cell
researchers; ability to culture up to 96,000 symmetrical stem cell development.
- CellAlign™ - tissue engineering applications for cardiac and nerve
tissue; biodegradable non-periodic "band-aid" structure for tissue
- ShrinkChip RPS™ - extremely low cost, highly flexible prototyping
solution for the manufacture of microfluidic biochips; patent-pending desktop
solution allows rapid design and fabrication of custom biochips.
- MetalFluor™ - diagnostic platform designed to inexpensively increase
the sensitivity and specificity of luminescent based assays; potential to
allow low-cost light detectors to enable more portable instrumentation for
- OptiSol™ Solar Concentrator - creating, trapping, and transporting
electrons; when 'wrinkled,' the surface becomes a 'light
trap' and tunes all radiation to optimal silicon absorbing wavelengths.
To learn more about these products and the technology, please visit http://www.shrinknano.com.
The presentation will be available to the public via a live web cast, which
may be accessed by visiting http://www.wsw.com/webcast/rrshq15/inkn.ob.